| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.0019 | 0.9 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.0031 | 1 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.0032 | 1 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |